Clinical Trial Update: An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL

View source ↗

Summary

An observational study evaluating dutasteride in combination with an alpha-blocker for symptomatic benign prostatic hyperplasia in men with PSA over 4 ng/mL.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Alpha blocker (unspecified)
• DUTASTERIDE (Dutasteride)

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Benign Prostatic Hyperplasia | Status: UNKNOWN